Basser Research Center for BRCA

Basser Research Center Grants

Reflecting the Center's mission to use cutting edge research in basic and clinical sciences to advance the care of individuals living with BRCA1 and BRCA2 mutations, grants are focused on innovative cancer research projects. Investigators who have already received peer-reviewed funding for their proposed projects will not be eligible for this award.

The scientific objective of the Basser Research Center for BRCA includes the funding of research projects related to BRCA1/2 ranging from basic science to clinical/translational research. Collaborative projects are strongly encouraged. Please note, the science must have relevance to the study of BRCA1/2 to be considered.

Read the 2014 Basser Research Center Grant press release.

Click here to find the list of 2014 Basser Research Center Grant Awardees.

Click here to find the list of past Basser Research Center Grant Awardees.


Internal Funding (for Penn investigators)

The Basser Research Center has the unique opportunity to catalyze the assembly of teams to change the paradigm of discovery, innovation, and care for issues related to BRCA1 and BRCA2 mutations. Germline mutations in BRCA1 and BRCA2 significantly increase the risk of breast and ovarian cancer and also are associated with prostate cancer and pancreatic cancer. Towards this end, the Basser Research Center is seeking applications for two types of grants:
  • Basser Breakthrough Science Team Awards from interdisciplinary groups of scientists who propose innovative team approaches to a variety of key focus areas.
  • Basser Outreach and Implementation Science Awards with the goal of reducing suffering and death from BRCA1 and BRCA2-associated cancer by undertaking research that will optimize genetic testing, risk assessment and clinical decision-making.

The Basser Internal Funding Program is currently closed and no longer accepting applications. Please check back in the Spring of 2015.


External Funding

The Basser Research Center for BRCA at Penn Medicine's Abramson Cancer Center announces the Basser External Research Grant Program, which focuses on projects that have the potential to advance the care of individuals living with BRCA1 and BRCA2 mutations. Research grant applications in basic science, early detection, translational or clinical research and relevant to the study of BRCA1/2 will be considered.

  • Basser Innovation Awards to external investigators interested in high-risk idea project.
  • Basser Team Science Awards to teams with a minimum of two principal investigators, with preference given to multi-institutional applications.

The Basser External Research Grants Program is currently closed and no longer accepting applications. Please check back in February 2015. For more information contact Cecilia Scavelli cecilia2@upenn.edu.